跳至主要内容
临床试验/ISRCTN15587630
ISRCTN15587630进行中(未招募)未知

Impact of a patient assistance program on the persistence of treatment with pirfenidone in patients with idiopathic pulmonary fibrosis

F. Hoffmann-La Roche AG0 个研究点目标入组 189 人开始时间: 2019年9月13日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
189

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Participants diagnosed with idiopathic pulmonary fibrosis
  • 2. Participants in whom their treating physician has decided, in partnership with them, to prescribe pirfenidone in accordance with the approved labelling
  • 3. Written informed consent provided

排除标准

  • 1. Concurrent participation in a clinical trial
  • 2. Participants unable to give consent as per investigator criteria

研究者

相似试验